| (11) | Number of the document | 4434 |
| (21) | Number of the application | a 2015 0097 |
| (22) | Filing date of the application | 2015.10.09 |
| | Date of filing the request for examination | (de fond) 09.10.2015 |
| (71) | Name(s) of applicant(s), code of the country | UNIVERSITATEA DE STAT DIN MOLDOVA, MD; |
| (72) | Name(s) of inventor(s), code of the country | PAHOLNITCAIA Anastasia, MD; POIRIER Donald, CA; TAPCOV Victor, MD; GULEA Aurelian, MD; |
| (73) | Name(s) of owner(s), code of the country | UNIVERSITATEA DE STAT DIN MOLDOVA, MD; |
| (54) | Title of the invention | Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor |
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | A61K 31/4433 (2006.01); A61K 31/175 (2006.01); A61P 35/02 (2006.01); |
| (19) | Country | MD |
| (45) | Date of publication of patent granting decision: | 2016.09.30 |
| (47) | Date of issuance of patent | 2017.04.30 |
| | Substantive examiner(s) | LEVIŢCHI Svetlana, JOVMIR Tudor |
| | Payment for maintenance up to the date | 2020.10.09 |
| | Date of patent termination | 2020.10.09 |
| | Date of publication of the termination of patent, with the right of restoration | 2021.05.31 |
| | Date of publication of the termination of patent, without the right of restoration | 2022.04.30 |